Abstract. The aim of the study was evaluate the 3.0 T magnetic resonance (MR) perfusion imaging scanning time window following contrast injection for differentiating benign and malignant breast lesions and to determine the optimum scanning time window for increased scanner usage efficiency and reduced diagnostic adverse risk factors. A total of 52 women with breast abnormalities were selected for conventional MR imaging and T1 dynamic-enhanced imaging. Quantitative parameters [volume transfer constant (K trans ), rate constant (K ep ) and extravascular extracellular volume fraction (V e )] were calculated at phases 10, 20, 30, 40 and 50, which represented time windows at 5, 10, 15, 20 and 25 min, respectively, following injection of contrast agent. The association of the parameters at different phases with benign and malignant tumor diagnosis was analyzed. MR perfusion imaging was verified as an effective modality in the diagnosis of breast malignancies and the best scanning time window was identified: i) Values of K trans and K ep at all phases were statistically significant in differentiating benign and malignant tumors (P<0.05), while the value of V e had statistical significance only at stage 10, but not at any other stages (P>0.05); ii) values of V e in benign tumors increased with phase number, but achieved no obvious changes at different phases in malignant tumors; iii) the optimum scanning time window of breast perfusion imaging with 3.0 T MR was between phases 10 and 30 (i.e., between 5 and 15 min after contrast agent injection). The variation trend of V e values at different phases may serve as a diagnostic reference for differentiating benign and malignant breast abnormalities. The most efficient scanning time window was indicated to be 5 min after contrast injection, based on the observation that the V e value only had statistical significance in diagnosis at stage 10. However, the optimal scanning time window is from 5 to 15 min following the injection of contrast agent, since that the variation trend of V e is able to serve as a diagnostic reference.
Introduction
Breast cancer is one of the most common malignant tumors endangering the health of women. Molybdenum-target mammography is the main screening method for breast cancer; however, the sensitivity of this method is only reported to be 69-90%, and the sensitivity in dense breast is decreased further to 48% (1, 2) . As magnetic resonance imaging (MRI) is widely adopted in clinical use, dynamic contrast enhancement MRI (DCE-MRI) has been applied for monitoring tumor angiogenesis and hemodynamic changes in order to provide valuable information for the diagnosis of lesions and the selection of treatment options. The meta-analysis conducted by Peters et al (3) , to evaluate the diagnostic efficacy of MRI for breast cancer, showed that the sensitivity and specificity were 90 and 72%, respectively. Numerous studies have been performed to evaluate magnetic resonance perfusion imaging in breast lesion diagnosis in recent years, but few studies have evaluated the optimized scanning window following contrast agent injection (4) (5) (6) .
Although MRI is recognized as a safer diagnostic modality compared with X-ray-based methods, certain biological effects such as perfusion and metabolism, and physical effects such as heating and motion may have compound adverse effects on diagnostic results (7, 8) . The determination of the optimum scanning window following contrast injection is of particular interest, as it should improve breast perfusion scanning efficiency and reduce adverse imaging effects, on the premise of utilizing the best quality images.
Therefore, the present study evaluated the image quality and diagnostic specificity of magnetic resonance perfusion images from different scanning windows following contrast injection and identified the most efficient and effective scanning window for breast lesions.
Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions Materials and methods
Patients. The study population comprised 52 female patients undergoing breast MRI dynamic enhanced scanning after they were found to have breast lumps using ultrasound examination and molybdenum target X-ray mammography. . Patients were injected with 20 ml intravenous high contrast agent gadobenate dimeglumine (Bracco Imaging S.p.A., Milan, Italy) after the second single phase scan, followed by 20 ml saline water injection at a flow rate of 5 ml/sec. Fifty continuous phase images were collected thereafter.
Image processing and evaluation. All data were transferred to a SYGNO VE40A workstation (Siemens AG) for post-processing using TISSUE 4D software. Arterial input functions (AIFs) at different times were acquired in obvious mammary gland artery or thoracic artery, selected manually in the images at phases of 10 (5 min after injection of contrast agents), 20 (10 min), 30 (15 min), 40 (min) 20 and 50 (25 min). Certain regions of interest (ROI), displayed by pseudo-color maps, were selected to measure the change of the following quantitative parameters in different pathology periods: i) Volume transfer constant (K trans ), describing the diffusion rate of the contrast agent from intravascular space to extravascular space; ii) the rate constant (K ep ), referring to the diffusion rate of the contrast agent from intracellular space to intravascular space; iii) extravascular extracellular volume fraction (V e ), indicating the ratio of the contrast agent permeated from extracellular space outside the vascular volume to the volume of the ROI. The criteria of ROI selection were regions without necrotic tissue, hollow space, calcification and blood vessels. Quantitative parameters for pathological identification were averaged over three consecutive slices containing the largest cross section of the selected abnormal lump zone.
Statistical analysis. SPSS software (version 17.0; SPSS, Inc., Chicago, IL, USA) was used for the study. Data are presented in the form of the mean ± standard deviation. Quantitative comparisons between benign and malignant tumor groups, and between various phases, were achieved using the t-test. P<0.05 was considered to indicate a statistically significant difference.
Results

Quantitative comparisons between benign and malignant tumor.
As shown in Tables I and II, Analysis of optimal scan window. 
Discussion
DCE-MRI is capable of detecting changes of the microvascular structures in tissue, and is particularly useful for the targeted imaging of tumor angiogenesis. Though the analysis of this imaging modality is rather simple, the three parameters K trans , K ep and V e are able to evaluate the contrast agent diffusion dynamics and hemodynamics in tissues accurately and improve the diagnostic efficacy for breast cancer patients (9) . They are effective indicators of the physiological state based on dual-compartmental pharmacokinetic model analysis, and therefore are widely adopted in tumor imaging study (10) . El Khouli et al (11) and some other studies suggest that K trans and K ep values are statistically significant in the diagnosis of benign and malignant breast tumors (12,13). Li et al (14) showed that the K trans value was distinctly higher in malignant breast lesions than in benign breast lesions. Amarnath et al (15) (17) showed that the K trans and K ep values of tumor tissue are markedly higher than those in the normal peripheral zone, while V e values indicated no significant difference between the two lesions. The diagnostic efficacy of changes in V e values in benign and malignant tumors remains debatable. The study by Koo et al (10) indicated that the values of V e would decrease as malignant breast tumor progresses to a higher stage. The present study shows that V e values have no significant difference between benign and malignant lesions which is consistent with the study by Ocak et al (17) . The authors of the present study attempted to observe the trend in changes by analyzing DCE images at multi-phases, and to explore the significance of the trend in the identification of lesions. The multiple phase analysis showed the that V e value increased in benign lesions as the scan phase increased, while it exhibited no obvious changes in malignant tissue. The slope of V e value change may be a valuable diagnosis surrogate in the differentiation of benign and malignant lesions. Our hypothesis for the interpretation of this phenomenon is that the endothelial structure is more mature in benign lesions than in malignant lesions; therefore, the filling of contrast agent into the interstitial structure changes with time in benign lesions, but remains steady in malignant lesions.
Few studies have been conducted for exploration of the optimized scanning time window of breast DCE-MRI, due to the large variety of scanning equipment, contrast agents and injection speed. In the present study, the scanning time window, was increased and the indicative parameters at multiple scan Table I . Indicator values in benign and malignant lesions (mean ± standard deviation). Table III . Statistical significance of differences between the three indicator values acquired at any two phases (P-value). 
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phases were analyzed, and a conclusion regarding the optimized scanning window following contrast injection was reached. The results demonstrated that the optimized scanning window is between phase 10 and phase 30, namely between 5 and 15 min after contrast injection, and the single scan time is 30 sec. In order to reduce scan time and achieve higher equipment usage efficiency, the best practice is scanning for 5 min following the contrast injection. In order to achieve better diagnostic specificity, the semi-quantitative indicator, time-intensity curve and the V e value change trend should be considered by scanning another 15 min after contrast injection.
In conclusion, this study shows that K trans and K ep values achieved from 3.0 T DCE-MRI have statistically significant value in the identification of benign and malignant breast lesions, and that the trend in V e value changes can also be used as a supplemental reference for specifying benign and malignant breast lesions. The optimized scanning window following contrast agent injection was determined based on the above analysis. Considering the great variety of scanning equipment, contrast agents and injection speeds, and the widely spaced time data points analyzed in this study, a large cohort of patients, more precise time data point analysis and more imaging sequence parameter comparison are required to provide stronger theoretical support for optimized breast DCE-MRI scanning time in further research.
